Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,915,115
+$1,575,610 QoQ
Shares Held
81,667
+28.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#253
of 1,348 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WealthTrust Axiom LLC holds $55,432,985 across 12 Drug Manufacturers - General names. NVO ranks #8 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,745 | $10,489,016 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
119,517 | $6,886,569 | |
| 3 | PFE |
Pfizer Inc
|
281,791 | $6,785,527 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
42,122 | $5,321,693 | |
| 5 | JNJ |
Johnson & Johnson
|
20,387 | $5,177,686 | |
| 6 | MRK |
Merck & Co., Inc.
|
40,221 | $5,168,398 | |
| 7 | NVS |
Novartis AG
|
32,676 | $5,120,982 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
81,667 | $3,915,115 |
All Filings in NVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,915,115 | 81,667 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,339,505 | 63,660 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,343,685 | 46,063 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,997,085 | 35,990 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,283,426 | 18,595 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $629,751 | 9,069 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||